Further evidence on the heterogeneity of "silent" serum cholinesterase variants.
D000109:Acetylcholine; D000327:Adsorption; D000498:Allyl Compounds / Q000494:pharmacology; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002802:Cholinesterases / Q000097:blood*; D003992:Dibucaine / Q000494:pharmacology; D004589:Electrophoresis, Disc; D004912:Erythrocytes / Q000201:enzymology; D005459:Fluorides / Q000494:pharmacology; D005796:Genes; D014644:Genetic Variation; D006720:Homozygote; D006801:Humans; D009526:Nialamide / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013438:Sulfhydryl Compounds
D000498:Allyl Compounds; D000906:Antibodies; D002800:Cholinesterase Inhibitors; D010636:Phenols; D000644:Quaternary Ammonium Compounds; D013438:Sulfhydryl Compounds; D002802:Cholinesterases; D003992:Dibucaine; D000109:Acetylcholine; D005459:Fluorides; D009526:Nialamide